733 results on '"Kullberg, Bart-Jan"'
Search Results
2. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications
3. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials
4. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study
5. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
6. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
7. Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections
8. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study
9. Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease
10. Lyme borreliosis : diagnosis and management
11. Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
12. Towards personalized medicine: a scoping review of immunotherapy in sepsis.
13. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris
14. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
15. Corrections to 'Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study' [The Lancet Regional Health – Europe 6 (2021) 100142] (The Lancet Regional Health - Europe (2021) 6, (S2666776221001198), (10.1016/j.lanepe.2021.100142))
16. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis
17. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis
18. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
19. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
20. Human TLR10 is an anti-inflammatory pattern-recognition receptor
21. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production
22. Classical Borrelia Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study.
23. Invasive candidiasis
24. Adoption of a national antimicrobial guide (SWAB-ID) in the Netherlands
25. Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital
26. Immune defence against Candida fungal infections
27. Reply to Anaissie and Nucci and to Cisneros et al
28. Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
29. Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
30. Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study
31. Genetic Variation in the Dectin-1/CARD9 Recognition Pathway and Susceptibility to Candidemia
32. Ocular Manifestations of Candidemia
33. Reply to Kontoyiannis
34. The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis
35. 1,25-dihydroxyvitamin D₃ Modulates Cytokine Production Induced by Candida albicans: Impact of Seasonal Variation of Immune Responses
36. Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis
37. Recognition of Borrelia burgdorferi by NOD2 Is Central for the Induction of an Inflammatory Reaction
38. Reactive Oxygen Species-Independent Activation of the IL-1β Inflammasome in Cells from Patients with Chronic Granulomatous Disease
39. Early Stop Polymorphism in Human DECTIN-1 Is Associated with Increased Candida Colonization in Hematopoietic Stem Cell Transplant Recipients
40. Reply to Kontoyiannis
41. Functional and Genetic Evidence That the Mal/TIRAP Allele Variant 180L Has Been Selected by Providing Protection against Septic Shock
42. Bypassing Pathogen-Induced Inflammasome Activation for the Regulation of Interleukin-1β Production by the Fungal Pathogen Candida albicans
43. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
44. Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
45. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
46. Immune Recognition of Candida albicans β-Glucan by Dectin-1
47. TLR4 Polymorphisms, Infectious Diseases, and Evolutionary Pressure during Migration of Modern Humans
48. Effect of Optimized Antibiotic Prophylaxis on the Incidence of Surgical Site Infection
49. Endogenous Interleukin (IL)-1α and IL-1β Are Crucial for Host Defense against Disseminated Candidiasis
50. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.